Theresa Podrebarac is a highly experienced individual who has worked in various leadership roles within the pharmaceutical and biotech industry. With a background in immunology and medicine, Theresa has held positions such as Senior Vice President Clinical Development, Chief Medical Officer, and Vice President of various therapeutic areas in companies like Amgen, Horizon, and Biogen. Their expertise lies in clinical development, immunology, rheumatology, and gene and cell-based therapies. Theresa has also been involved in bringing transformative therapies to patients with rare diseases like Dystrophic Epidermolysis Bullosa. Throughout their career, Theresa has demonstrated strong leadership and strategic vision in developing innovative treatments for patients in need.
November, 2023 - present